High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy

Annals of Oncology

Volumn 7, Issue 2, 1996, Pages 151-156

  Bierman, P J ^a,b   Anderson, J R ^b   Freeman, M B ^a   Vose, J M ^a   Kessinger, A ^a   Bishop, M R ^a   Armitage, J O ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Bone marrow transplantation; Drug therapy; Hematopoietic stem cell transplantation; Hodgkin's disease

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; MESNA;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; FEMALE; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SURVIVAL;

EID: 0029918551     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010542     Document Type: Article

References (29)

1. Phillips GL, Wolff SN, Herzig RH et al. Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation. Blood 1989; 73: 2086-92.
2. Reece DE, Barnett MJ, Connors JM et al. Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol 1991; 9; 1871-9.
3. Chopra R, McMillan AK, Linch DC et al. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients. Blood 1993; 81: 1137-45.
4. Crump M, Smith AM, Brandwein J et al. High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: Importance of disease status at transplant. J Clin Oncol 1993; 11: 704-11.
5. Bierman PJ, Bagin RG, Jagannath S et al. High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: Long term follow-up in 128 patients. Ann Oncol 1993; 4: 767-73.
6. Rapoport AP, Rowe JM, Kouides PA et al. One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: Value of pretransplant disease status for predicting outcome. J Clin Oncol 1993; 11: 2351-61.
7. Nademanee A, O'Donnell MR, Snyder DS et al. High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: Results in 85 patients with analysis of prognostic factors. Blood 1995; 85: 1381-90.
8. Buzaid AC, Lippman SM, Miller TP. Salvage therapy of advanced Hodgkin's disease. Am J Med 1987; 83: 523-32.
9. Canellos GP. Is there an effective salvage therapy for advanced Hodgkin's disease? Ann Oncol 1991; 2 (Suppl 1): 1-7.
10. Bishop MR. Anderson JR. Jackson JD et al. High-dose therapy and peripheral blood progenitor cell transplantation: Effects of recombinant human granulocyte-macrophage colony-stimulating factor on autograft. Blood 1994; 83: 610-6.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
12. Cox DR. Regression models and life-tables. J R Stat Soc 1972; 34: 187-202.
13. Klimo P, Connors JM. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with MOPP/ABV hybrid program. Semin Hematol 1988; 25 (Suppl 2): 34-40.
14. Fisher RI, DeVita VT, Hubbard SP et al. Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. Ann Intern Med 1979; 90: 761-3.
15. Longo DL, Duffey PL, Young RC et al. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: The low probability for cure. J Clin Oncol 1992; 10: 210-8.
16. Canellos GP, Anderson JR, Propert KJ et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992; 327: 1478-84.
17. Viviani S, Santoro A, Negretu E et al. Salvage chemotherapy in Hodgkin's disease. Ann Oncol 1990; 1: 123-7.
18. Bonadonna G, Santoro A, Gianni AM et al. Primary and salvage chemotherapy in advanced Hodgkin's disease: The Milan Cancer Institute experience. Ann Oncol 1991; 2 (Suppl 1): 9-16.
19. Bonfante V, Santoro A, Devizzi L et al. Outcome of patients with Hodgkin's disease relapsing after alternating MOPP/ABVD. Proc Am Soc Clin Oncol 1993; 12: 364 (Abstr 1231).
20. Tourani J-M, Levy R, Colonna P et al. High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's disease. J Clin Oncol 1992; 10: 1086-94.
21. Pfreundschuh MG, Rueffer U, Lathan B et al. Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: A trial for the German Hodgkin's Disease Study Group. J Clin Oncol 1994; 12: 580-6.
22. Reece DE, Connors JM, Spinelli JJ et al. Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood 1994; 83: 1193-9.
23. Desch CE, Lasala MR, Smith TJ et al. The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse. J Clin Oncol 1992; 10: 200-9.
24. Brandwein JM, Callum J, Sutcliffe SB et al. Evaluation of cytoreductive therapy prior to high dose treatment with autologous bone marrow transplantation in relapsed and refractory Hodgkin's disease. Bone Marrow Transplant 1990; 5: 99-103.
25. Demirer T, Buckner CD, Lilleby K et al. Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease. Cancer 1994; 74: 715-21.
26. Clift RA, Buckner CD, Thomas ED et al. The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation. Bone Marrow Transplant 1987; 2: 243-58.
27. Darrington DD, Vose JM, Anderson JR et al. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol 1994; 12: 2527-34.
28. Linch DC, Winfield D, Goldstone AH et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease; Results of a BNLI randomised trial. Lancet 1993; 341: 1051-4.
29. Yuen AR, Blume KG, Rosenberg SA et al. Comparison between autologous bone marrow transplantation (ABMT) and conventional salvage therapy for recurrent or refractory Hodgkin's disease. Blood 1994; 10 (Suppl 1): 234a.